发明名称 Protease resistant modified erythropoietin polypeptides
摘要 Modified erythropoietin polypeptides that include the mutation R131Q, and uses thereof are provided. Also provided are pharmaceutical compositions, including compositions formulated for oral administration, that contain the modified erythropoietin polypeptides and uses of the compositions to treat diseases and conditions treated by erythropoietin.
申请公布号 US8114839(B2) 申请公布日期 2012.02.14
申请号 US20080157150 申请日期 2008.06.06
申请人 GANTIER RENE;VEGA MANUEL;DRITTANTI LILA;GUYON THIERRY;HANALL BIOPHARMA CO., LTD. 发明人 GANTIER RENE;VEGA MANUEL;DRITTANTI LILA;GUYON THIERRY
分类号 A61K38/18;A01N25/34;A61K38/00;C07K14/475;C07K14/505;C07K14/52;C07K14/53;C07K14/535;C07K14/54;C07K14/555;C07K14/56;C07K14/575;C07K14/61;C12N15/19;C12N15/20;C12N15/24 主分类号 A61K38/18
代理机构 代理人
主权项
地址